×
Third quarter 2026 sales climbed roughly 9% year over year to $5.12 billion , up from $4.71 billion in the prior-year period. Comparable store sales — a measure of sales at locations open at least a year — increased 7.2% , reflecting resilient demand across the aftermarket.
ASBP is a micro-cap company blending sublingual drug-delivery technology with automotive and industrial control systems, while SPRO is a clinical-stage biopharmaceutical focused on multi-drug resistant (MDR) bacterial infections. The two names operate at very different scales: ASBP carries a market capitalization near $12 million, whereas SPRO trades near a $65 million valuation with meaningfully higher liquidity.
MKDW is trading down about -33% during regular hours, near $0.28 versus Monday's $0.4175 close. The decline reverses the prior session's +20.53% speculative surge on roughly 20.8M shares versus a ~90k average.
THRM is up +10.84% (about +$3.10) to $31.69, rising during regular market hours after closing the prior session at $28.59. The primary catalyst is an analyst upgrade: Freedom Broker raised Gentherm to Buy from Hold with a $40 price target, citing the recent pullback in shares.
Dorman Products reported third-quarter 2026 net sales of $561.7 million, up 3.3% from $543.7 million a year earlier. GAAP diluted earnings per share (EPS) came in at $1.98, down from $2.48 in the prior-year quarter, as gross margin narrowed to 39.4% from 44.4%.
The central $27 stock price target is the arithmetic mean of eight verified analyst price targets collected from firms including Jefferies, J.P. Morgan, Barclays, Roth Capital, Argus, Raymond James, Robert W. Baird, and Stephens. At a latest verified price of roughly $17.42, reaching $27 would require an upside of about 55%, a very large move from current levels.
Portfolio simplification is the central catalyst: The board has launched a comprehensive review of strategic alternatives, including a possible sale of the company, while separately pursuing a divestiture of the Specialty segment. North America is inflecting: The Wholesale–North America segment returned to positive organic growth in mid-2026 for the first time in nine quarters, aided by record alternative parts utilization.
LKQ closed at $17.42 on Friday, down -22.47% from the prior session's $22.47 close—a rare move for this low-volatility auto-parts distributor. The decline unfolded during the regular session, extending a premarket gap of more than -16%.
Dorman Products is scheduled to report third-quarter 2026 results after the market closes on Monday, October 26, 2026, with a conference call the following morning. Wall Street consensus calls for earnings of roughly $2.00 per share on revenue of about $565 million, compared with $2.62 per share and $543.7 million in the year-ago quarter.
Strategic repositioning underway: Following its September 2026 name change and the acquisition of Dura Control Systems Corp., Aspire-Lakewood now spans two distinct businesses — a patent-pending sublingual drug-delivery platform and automotive/industrial control systems. Lead-candidate progress is a defining catalyst: The development path for Sublingual High Dose Aspirin, plus pipeline assets such as sublingual alprazolam and consumer supplements, will shape the company's long-term therapeutic value.
The $10 central target is a psychological, round-number milestone derived from public market discussion, not an analyst consensus — ASBP has essentially no sell-side analyst coverage. At a latest verified price near $8.80, reaching $10 would require a gain of roughly 14%, a modest move for this highly volatile micro-cap but a substantial one in risk-adjusted terms.
Aspire-Lakewood Holdings (ASBP) is a Nasdaq Capital Market micro-cap that pairs sublingual drug-delivery technology with automotive and industrial control systems following its acquisition of Dura Control Systems Corp. Shares closed at $8.75 on October 23, 2026, roughly 5% higher than the $8.33 close about 30 days earlier, a modest move that reflects rangebound trading rather than a sharp directional shift.
AZO (AutoZone) and ORLY (O'Reilly Automotive) are two of the largest automotive aftermarket parts retailers in the United States, competing across both do-it-yourself and professional repair channels. O'Reilly has shown stronger recent comparable store sales (same-store sales) momentum, with growth of 6% in its latest quarter and 33 consecutive years of comparable store sales growth.
SES AI (SES) is trading down roughly -8.22% to about $0.67 during regular session hours, giving back part of the prior session's +15.21% surge. No company-specific negative news emerged today; the decline reflects profit-taking following the Oct. 22 rally sparked by the Chungju drone-battery plant ramp to one million NDAA-compliant cells and expansion plans to three million by Q2 2027.
Visteon (VC) is down about -7.26% today, trading near $75.77 versus a prior close of $81.70 during regular market hours. The move extends a post-earnings selloff after Q3 results: a $77 million warranty charge cut net income roughly 91% and drove EPS to $0.19 versus the $2.33 consensus estimate.
GNTX is down -5.29% intraday, trading near $20.59 after closing at $21.74 in the prior session, with the decline extending during regular market hours after a premarket sell-off. Q3 results released before the open missed estimates: adjusted EPS of $0.47 versus $0.51 consensus and revenue of $647.7M versus roughly $669.6M expected.
LKQ shares are down -20.52% during Friday's session, falling to $17.86 from a prior close of $22.47, after gapping sharply lower in premarket trading. The drop followed preliminary Q3 results that missed estimates, with revenue of $3.32B and adjusted EPS of $0.47–$0.53 versus $0.69 expected, plus a projected net loss of $16M–$32M.
Product revenue reached $405.1 million , up 4.7% year over year, narrowly topping consensus estimates of roughly $404 million. Adjusted diluted earnings per share (EPS) came in at $0.33 , well below the consensus of about $0.65, driven by higher tax rates tied to deal costs.
Visteon reported third-quarter 2026 sales of $970 million , up 5.8% year over year and above analyst estimates. Adjusted earnings per share (EPS) came in at $0.19 , well below the consensus estimate of roughly $2.28 per share.
Garrett Motion Inc. (NASDAQ: GTX) is scheduled to report its third quarter 2026 financial results on Thursday, October 29, 2026, before U.S. market open. Consensus estimates point to adjusted earnings per share (EPS) of roughly $0.48 to $0.51 and net sales of approximately $940 million to $950 million.